Medicines - From Targets To Novel Drugs Grants 2015-2 (€ 125,000)

Bayer HealthCare invites proposals for its From Targets To Novel Drugs Grants. Deadline of submissions is August 31, 2015. Bayer HealthCare allocates grants for the exploration of attractive, novel drug targets in the fields of oncology, gynecology, cardiology and hematology. Researchers from universities, other academic research institutes and start-up companies from all over the world are eligible to apply.

There are two different types of grants available:
• Support Grants: € 5,000 - € 10,000;
• Focus Grants: € 10,000 - € 125,000.

With this initiative, Bayer HealthCare aims to encourage research on novel targets in areas of mutual interest. By combining expertise from industry and academia, the institute intends to accelerate the transition from basic research to new promising treatment options.